$OBIO
Orchestra BioMed Holdings, Inc. operates as a biomedical innovation company. The company's flagship product candidates include BackBeat Cardiac Neuromodulation Therapy (CNT) for the treatment of hypertension; and Virtue Sirolimus AngioInfusion Balloon (SAB) for the treatment of atherosclerotic artery disease. Its products also comprise FreeHold retractors that are minimally invasive surgical device solutions. The company has a strategic collaboration with Medtronic for the development and commercialization of BackBeat CNT for the treatment of hypertension in pacemaker-indicated patients; and a strategic partnership with Terumo Corporation for the development and commercialization of Virtue SAB for the treatment of artery disease. Orchestra BioMed Holdings, Inc. is based in New Hope, Pennsylvania.
Healthcare
Sector
Biotechnology
Industry
David Hochman
CEO
70
Employees
$6.15
Current Price
$149.23M
Market Cap
Insider Activity Statistics
Aggregated buying and selling activity by time period
| Period | Type | Insiders | Transactions | Value | Shares | Buy/Sell Ratio |
|---|---|---|---|---|---|---|
| 1 week | Buys | 5 | 5 | $6,230,000.00 | 1,246,000 | All Buys |
| Sells | 0 | 0 | - | - | ||
| 2 weeks | Buys | 5 | 5 | $6,230,000.00 | 1,246,000 | 72.36:1 |
| Sells | 1 | 1 | $86,100.00 | 15,000 | ||
| 1 month | Buys | 5 | 5 | $6,230,000.00 | 1,246,000 | 72.36:1 |
| Sells | 1 | 1 | $86,100.00 | 15,000 | ||
| 2 months | Buys | 5 | 5 | $6,230,000.00 | 1,246,000 | 34.33:1 |
| Sells | 1 | 2 | $181,500.00 | 30,000 | ||
| 3 months | Buys | 6 | 7 | $6,288,560.00 | 1,258,000 | 24.60:1 |
| Sells | 1 | 3 | $255,600.00 | 45,000 | ||
See activity going back 12 months โ create a free account | ||||||
Insider Transactions
Recent purchases and sales by company insiders
| Date | Insider | Type | Shares | Price | Value | Actions |
|---|---|---|---|---|---|---|
| Nov 9, 2026 | RTW INVESTMENTS, LP 10% Owner | Purchase | 1,200,000 | $5.00 | $6,000,000.00 | View Details |
| Nov 9, 2026 | Fain Eric S Director | Purchase | 20,000 | $5.00 | $100,000.00 | View Details |
| Nov 9, 2026 | Pacitti David Director | Purchase | 20,000 | $5.00 | $100,000.00 | View Details |
| Nov 9, 2026 | Hochman David P Director | Purchase | 5,000 | $5.00 | $25,000.00 | View Details |
| Nov 9, 2026 | Taylor Andrew Lawrence Chief Financial Officer | Purchase | 1,000 | $5.00 | $5,000.00 | View Details |
| Nov 2, 2026 | Sherman Darren Director | Sale | 15,000 | $5.74 | $86,100.00 | View Details |
| Oct 1, 2026 | Sherman Darren Director | Sale | 15,000 | $6.36 | $95,400.00 | View Details |
| Sep 3, 2026 | Hochman David P Director | Purchase | 10,000 | $4.79 | $47,900.00 | View Details |
| Sep 1, 2026 | Sherman Darren Director | Sale | 15,000 | $4.94 | $74,100.00 | View Details |
| Aug 26, 2026 | Sherman Darren Director | Purchase | 2,000 | $5.33 | $10,660.00 | View Details |
11 more transactions available โ create a free account to see 12 months of history | ||||||
Upcoming Earnings
Scheduled earnings reports
No upcoming earnings scheduled
Past Earnings
Historical earnings results
EPS
Estimated-$0.40
Actual-$0.30
Beat
Revenue
Estimated$129.43K
Actual$91.00K
Miss
EPS
Estimated-$0.40
ActualN/A
Revenue
Estimated$129.43K
ActualN/A
1 more earnings records available โ create a free account to see 12 months of history
Related Activity
Cross-company insider connections and cluster buy signals
Insiders Also Active At
Insiders at this company also hold positions or have traded at these companies: